Samaxia Ltd Introduces LacriProtect® and Lacri+®: Leading Innovations in Canine Ocular Comfort

30th October 2024
Industry News

UK, October 2024 – Samaxia Ltd, headquartered in Lincoln, is proud to announce the exclusive UK distribution of MP Labo’s latest eye care innovations, LacriProtect® and Lacri+®. These products are expertly designed to support ocular comfort and are now exclusively available to veterinary practices throughout the UK.
Advanced Eye Care Solutions
Developed by MP Labo, a French company renowned for its respect for animals and respect for nature to preserve the fragile balances of our environment, these innovative eye care products have been tailored to enhance the comfort of dogs:
•LacriProtect® offers a unique carbomer-based formula in individual, resealable single-use pipettes, ensuring each application is hygienic and free from cross-contamination. This feature is particularly advantageous in clinical settings where maintaining sterility is crucial.
•Lacri+®, featuring 0.4% cross-linked sodium hyaluronate and urea, is designed for sustained ocular surface hydration. Its innovative multi-dispense bottle with a tip-seal mechanism and multilayer filtration ensures sterility and shelf life of three months after opening, providing long-term usability and convenience for regular use.

Features, Advantages, and Benefits•LacriProtect®:
Feature: Single-use, resealable pipettes.
Advantage: Prevents cross-contamination, enhancing clinical hygiene and safety.
Benefit: Offers veterinarians and pet owners a safe and efficient way to manage ocular comfort without the risk of infection.

•Lacri+®:
oFeature: Preservative-free formula with a patented delivery system and a shelf life of three months after opening.
oAdvantage: Extends the usability of the product, reducing the frequency of purchasing replacements.
oBenefit: Ensures ongoing comfort and protection for dogs with dry eyes, supporting better quality of life with fewer interruptions in care.

Available from NVS now